Pharmacoepidemiology and Drug Safety

Article	Citations
Statins and risk of diverticular disease: Nested case–control study	56
Effect of 5‐HT2C receptor gene polymorphism (HTR2C−759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone	49
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient‐reported COVID‐19 experiences	40
Issue Information	34
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	30
INSIGHT: A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	28
Predictors of Potentially Inappropriate Stimulant Prescribing Among Adults	27
Success of the German Cystic Fibrosis Registry	23
Data Resource Profile: The Danish National Hospital Medicine Register	23
Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records	23
Validity of inpatient electronic health record‐based measures of oxygen‐related therapy in the United States: Lessons applicable for studying COVID‐19 endpoints	22
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	22
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study	22
	21
	20
Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies	20
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	19
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology	19
Delayed pregnancy detection and return to fertility with extended levonorgestrel‐containing oral contraceptives: A real world setting cohort study	19
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	19
A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update	18
	18
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries	17
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	17
Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis	17

Prescriber perceptions of boxed warnings: A qualitative study	16
Issue Information	16
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997–2011	15
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018	15
Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations	15
External validity in distributed data networks	14
The use of uncertain exposure—A method to define switching and add‐on in pharmacoepidemiology	14
	14
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization	14
Issue Information	14
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross‐sectional OPTIMUS study	13
Validity of self‐reports of medication treatment of depression in general population surveys	13
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment	13
Issue Information	13
Issue Information	13
AfRIG 2021 Virtual Meeting	12
Validation of coding algorithms for the identification of herpes zoster among children	12
Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus	12
	12
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology	12
Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults	11
Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making	11
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers	11
A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case	11
Development and validation of case‐finding algorithms to identify acute pancreatitis in the Veterans Health Administration	11
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	11
Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy	11
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	11
Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum	11
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022	10
Issue Information	10
Identification of risk factors for adverse drug reactions in a pharmacovigilance database	10
	10
Issue Information	10
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	10
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	10
A strategy for assessment and validation of major bleeding cases in a primary health care database in Spain	10
Issue Information	9
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies	9
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	9
	9
Issue Information	9
Development and validation of case‐finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data	9
Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes	8
An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries	8
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus	8
Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney	8
Methods to refine and extend a Pregnancy Register in the UK Clinical Practice Research Datalink primary care databases	8
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature	8
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe	8

Issue Information	8
Issue Information	8
The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis	8
Validation of serostatus of rheumatoid arthritis using ICD‐10 codes in administrative claims data	8
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database	8
Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM	8
STUDENT ABSTRACTS of ISPE's 2023 Mid‐Year Meeting, Reykjavik, Iceland, 23–25 April 2023	8
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism	8
A descriptive analysis of postmarketing requirement studies and clinical trials	8
Identifying inpatient mortality in MarketScan claims data using machine learning	8
Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan	8
Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan	8
Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance	7
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase	7
Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case‐time‐control design	7
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database	7
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	7
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	7
Predicting obesity and smoking using medication data: A machine‐learning approach	7
Evaluation of more than one billion outpatient prescriptions and eight‐year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interv	7
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies	7
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	7
Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25–27 August 2023	7
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	7
Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases	7
Linkage of public health and all payer claims data for population‐level opioid research	7
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model	7
Core Concepts in Pharmacoepidemiology: New‐User Designs	6
Validation studies of Japanese administrative health care data: A scoping review	6
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting	6
Matching study design to prescribing intention: The prevalent new‐user design for studying abuse‐deterrent formulations of opioids	6
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes	6
Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain	6
Effectiveness of Baricitinib Risk Minimization Activities in Patients With Rheumatoid Arthritis—A Cohort Study in Four Nordic Countries	6
Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies	6
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	6
Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines	6
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	6
	6
Issue Information	6
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review	6
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe	6
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	6
A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data	6
Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐bas	6
Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK<	6
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy	6
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System	6
Non‐adherence and non‐persistence with antiretroviral treatment in Belgium: A real‐world evaluation using a pharmacy database, 2018–2021	6
Mobile apps for quick adverse drug reaction report: A scoping review	6
Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark	6
Corrigendum to “Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden – a population‐based register study”	6
Predicting risk of suicidal behavior from insurance claims data vs. linked data from insurance claims and electronic health records	6
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	6
Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort	5
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk	5
Cover Image, Volume 33, Issue 8	5
Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study	5
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis	5
Issue Information	5
Barbro Westerholm, 1933–2023	5
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	5
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	5
Real world prescription of beta‐blockers in patients with asthma	5
Issue Information	5
Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims	5
Issue Information	5
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	5
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	5
Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database	5
Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases	5
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”	5
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy	5
A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions	5
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	5
Validity of hospital ICD‐10‐GM codes to identify anaphylaxis	5
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors	4
Assessing cumulative effects of medication use: New insights and new challenges	4
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	4
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome	4

Observed‐over‐Expected analysis as additional method for pharmacovigilance signal detection in large‐scaled spontaneous adverse event reporting	4
Adverse drug reactions and hospital admissions: Large case‐control study of patients aged 65–100 years using linked English primary care and hospital data	4
Systematically exploring repurposing effects of antihypertensives	4
Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches	4
Identification of Chronic Hypertension in Pregnancy in Three Administrative Data Sources Among Medicaid‐Funded Births in California	4
Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series	4
Trajectories of opioid consumption as predictors of patient‐reported outcomes among individuals attending multidisciplinary pain treatment clinics	4
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	4
Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study	4
Beta‐blocker use and survival after pancreatic cancer surgery: A nationwide population‐based cohort study	4
Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depression	4
A case for screening real‐world data for collateral drug benefits: Glucagon‐like peptide 1 receptor agonists and bile acid diarrhea	4
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study	4
Oral phosphodiesterase type 5 inhibitors and priapism: A VigiBase analysis	4
Gout and sodium‐glucose cotransporter‐2 inhibitors	4
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	4
A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer	4
How to account for early overly small risk sets in the analysis of pregnancy outcome data?—Comparison of different methods for stabilizing the Aalen‐Johansen estimator	4
Effect of ICD‐9‐CM to ICD‐10‐CM coding system transition on identification of common conditions: An interrupted time series analysis	4
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom	4
Trends in strong opioid prescribing in Ireland: A repeated cross‐sectional analysis of a national pharmacy claims database between 2010 and 2019	4
Profiling real‐world data sources for pharmacoepidemiologic research: A call for papers	4
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact	4
	4
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	4
Signal detection of adverse events associated with gabapentinoid use for chronic pain	4
Generating Real‐World Evidence From the Excellence Network in Rheumatology	3
Stratified analysis in comparative effectiveness studies that emulate randomized trials	3
Issue Information	3
Nonsteroidal anti‐inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta‐analysis	3
Issue Information	3
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD	3
Tying research question and analytical strategy when variables are affected by medication use	3
	3
Issue Information	3
Issue Information	3
Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study	3
Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?	3
Issue Information	3
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases	3
	3
Pandemic vaccine testing: Combining conventional and challenge studies	3
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS‐3 Trial	3
Uncommon side effects of common drugs in patients with familial dysautonomia	3
Association between adherence to warfarin and thrombotic events in patients with antiphospholipid syndrome in Japan: A claims‐based retrospective cohort study	3
Issue Information	3
Record linkage of claims and cancer registries data—Evaluation of a deterministic linkage approach based on indirect personal identifiers	3
The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database	3
Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics	3
Cover Image, Volume 30, Issue 9	3
Reviewers of manuscripts submitted in 2020	3
The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis	3
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	3
Bayesian symmetry analysis	3
Commentary/Response to Damkier et al.	3
Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study	3
Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID‐19 Adenovirus Vector Vaccines on European Healthcare Professionals	3
Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice	3
Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation	3
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data	3
Issue Information	3
Statin (mis)use in older people: A cross‐sectional study using French health insurance databases	3
	3
Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy	3
Opioid prescribing and risks among commercially insured women undergoing pelvic organ prolapse repair	3
Issue Information	3
The impact of regulation changes in the spontaneous reporting system for vaccines on reporting trends and signal detection in Japan	3
ISPE MidYear 2021	3
Issue Information	3
Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018	3
Trends in antipsychotic use for youth with attention‐deficit/hyperactivity disorder and disruptive behavior disorders	3